|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
10.78(B) |
Last
Volume: |
176,534 |
Avg
Vol: |
474,971 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
10 |
16 |
28 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ackerman Thomas F |
Corporate Executive VP & CFO |
|
2015-05-15 |
4 |
OE |
$37.92 |
$189,600 |
D/D |
5,000 |
105,635 |
|
- |
|
Ackerman Thomas F |
Corporate Executive VP & CFO |
|
2015-05-15 |
4 |
AS |
$70.94 |
$78,168 |
D/D |
(1,100) |
100,635 |
|
- |
|
Massaro George |
Director |
|
2015-05-07 |
4 |
AS |
$69.98 |
$95,487 |
D/D |
(1,360) |
15,120 |
|
- |
|
Massaro George |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
16,480 |
|
- |
|
Chubb Stephen D |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
17,504 |
|
- |
|
Thompson Craig B. |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
8,590 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
10,740 |
|
- |
|
Milne George M Jr |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
32,760 |
|
- |
|
Reese C Richard |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
24,911 |
|
- |
|
Wallman Richard F |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
18,150 |
|
- |
|
Bertolini Robert J |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
17,890 |
|
- |
|
Chubb Stephen D |
Director |
|
2015-05-01 |
4 |
AS |
$69.80 |
$139,595 |
D/D |
(2,000) |
15,534 |
|
- |
|
Chubb Stephen D |
Director |
|
2015-04-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
320 |
17,534 |
|
- |
|
Ackerman Thomas F |
Corporate Executive VP & CFO |
|
2015-03-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
100,635 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2015-03-27 |
5 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
334,262 |
|
- |
|
Crowley John J |
SVP, Chief Accounting Officer |
|
2015-03-04 |
4 |
S |
$76.52 |
$69,792 |
D/D |
(912) |
5,219 |
|
- |
|
Crowley John J |
SVP, Chief Accounting Officer |
|
2015-03-04 |
4 |
OE |
$59.41 |
$54,182 |
D/D |
912 |
6,131 |
|
- |
|
Chubb Stephen D |
Director |
|
2015-03-03 |
4 |
S |
$75.52 |
$151,047 |
D/D |
(2,000) |
17,854 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2015-03-02 |
4 |
AS |
$76.80 |
$156,625 |
D/D |
(2,036) |
340,262 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2015-03-02 |
4 |
AS |
$76.58 |
$727,051 |
D/D |
(9,483) |
342,298 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2015-03-02 |
4 |
AS |
$76.41 |
$654,091 |
D/D |
(8,552) |
351,781 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2015-03-02 |
4 |
OE |
$59.41 |
$1,192,418 |
D/D |
20,071 |
360,333 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2015-03-02 |
4 |
S |
$76.53 |
$199,137 |
D/D |
(2,600) |
8,770 |
|
- |
|
Gillett Nancy |
Corporate Executive VP |
|
2015-03-02 |
4 |
S |
$76.70 |
$335,949 |
D/D |
(4,379) |
18,210 |
|
- |
|
Gillett Nancy |
Corporate Executive VP |
|
2015-03-02 |
4 |
OE |
$59.41 |
$260,156 |
D/D |
4,379 |
22,589 |
|
- |
|
1200 Records found
|
|
Page 43 of 48 |
|
|